Get started
Author

Shuanying Yang

Observed names: Shuan-Ying Yang, Shuan-ying Yang
OpenAlex ID: A5115592818
Circ_0076305 regulates cisplatin resistance of non-small cell lung cancer via positively modulating STAT3 by sponging miR-296–5p
2019 · Yu Dong, Tao Xu, et al. · Life Sciences · 104
Elevation of serum l-lactate dehydrogenase B correlated with the clinical stage of lung cancer
2006 · Yue Chen, Hao Zhang, et al. · Lung Cancer · 60
Engineering conductive antioxidative antibacterial nanocomposite hydrogel scaffolds with oriented channels promotes structure-functional skeletal muscle regeneration
2021 · Juan Ge, Yannan Li, et al. · Chemical Engineering Journal · 47
Serum amyloid A protein: a potential biomarker correlated with clinical stage of lung cancer.
2007 · Dan-Hui Liu, Xiao-Min Wang, et al. · PubMed · 42
A bionic “Trojan horse”-like gene delivery system hybridized with tumor and macrophage cell membrane for cancer therapy
2023 · Tianli Shen, Shuanying Yang, et al. · Journal of Controlled Release · 34
Multifunctional antibacterial bioactive nanoglass hydrogel for normal and MRSA infected wound repair
2023 · Long Zhang, Wen Niu, et al. · Journal of Nanobiotechnology · 32
PDF
STMN1 Promotes Tumor Metastasis in Non-small Cell Lung Cancer Through Microtubule-dependent And Nonmicrotubule-dependent Pathways
2024 · Lizhong Zeng, Xin Lyu, et al. · International Journal of Biological Sciences · 26
PDF
Bioactive cytomembrane@poly(citrate-peptide)-miRNA365 nanoplatform with immune escape and homologous targeting for colon cancer therapy
2022 · Long Zhang, Wan Zhang, et al. · Materials Today Bio · 25
PDF
Innovative Oral Nano/Gene Delivery System Based on Engineered Modified Saccharomyces cerevisiae for Colorectal Cancer Therapy
2024 · Tianli Shen, Xuejun Sun, et al. · ACS Nano · 17
Pretreatment HDL‐C and ApoA1 are predictive biomarkers of progression‐free survival in patients with EGFR mutated advanced non‐small cell lung cancer treated with TKI
2022 · Juan Ma, Ying Bai, et al. · Thoracic Cancer · 12
PDF
Biomarker discovery and identification from non-small cell lung cancer sera
2010 · Shuan-ying Yang · Frontiers in Bioscience-Elite · 11
PDF
hnRNPA2B1 potentiates the immune escape of non-small cell lung cancer by accelerating tumor microenvironment acidification
2025 · Yiqun Wei, Weijie Li, et al. · Free Radical Biology and Medicine · 9
TMBquant: an explainable AI-powered caller advancing tumor mutation burden quantification across heterogeneous samples
2025 · Shenjie Wang, Xiaonan Wang, et al. · Briefings in Bioinformatics · 2
PDF
Long non-coding RNA PRKG1-AS1 promotes cell proliferation and migration in lung adenocarcinoma
2025 · Tong Jiao, Haimei Wen, et al. · Respiratory Research · 1
PDF
[Expression and clinicopathological significance of CD44V6 expression in non-small cell lung cancer].
2002 · Li Sun, Jun Han, et al. · PubMed · 1
A tumor microenvironment acid-responsive therapy combining fenton chemistry and chemotherapy via TNF pathway for synergistic and safe lung cancer treatment
2026 · Cai Zhang, Long Zhang, et al. · Journal of Nanobiotechnology
Serum cytokine profiles in a real-world cohort of KRAS-Mutant NSCLC and its therapeutic implications for subtype-specific immunotherapy
2026 · Bo Yuan, Yuanyi Zhang, et al. · Respiratory Research
[Application of laser capture microdissection and surface-enhanced laser desorption ionization time-of-flight mass spectrometry to screen biomarkers for early diagnosis of lung adenocarcinoma].
2009 · Ying-Xuan Tian, Shuan-Ying Yang, et al. · PubMed
Works count: 18
Citation count: 423
H-index: 11
I10-index: 11
Year
Topic
Type